Is There a Place for Complement Inhibition with Monoclonal Anti-C5a Antibody Vilobelimab in the Treatment of Patients with ANCA-associated Vasculitis?
| Autor: | Gheriani, Gatr-Alnada1, Kumar, Bharat1, Lenert, Petar S.1 petar-lenert@uiowa.edu |
|---|---|
| Zdroj: | touchREVIEWS in RMD. 2022, Vol. 1 Issue 2, p46-49. 4p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|